Do Patient Characteristics Matter When Calculating Sample Size for Eczema Clinical Trials?
Laura Howells(University of Nottingham), Kim S Thomas(University of Nottingham), Miriam Santer(NIHR Southampton Biomedical Research Centre), Sonia Gran(University of Nottingham), Louise A. A. Gerbens(Amsterdam Neuroscience), Daisy Gaunt(University of Bristol), Lucy Bradshaw(University of Nottingham), Joanne R Chalmers(University of Nottingham), Phyllis I. Spuls, Beth Stuart(University of Southampton), Nick Francis(Cochrane), Chenchen Huang(University of Hull), Matthew J Ridd(University of Bristol)
Cited by 3
Related Papers
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
|Journal of Investigative Dermatology|2016|377
Towards global consensus on outcome measures for atopic eczema research: results of the <scp>HOME II</scp> meeting
|Allergy|2012|189
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study
|Journal of Allergy and Clinical Immunology|2020|160
Epidemiology of molluscum contagiosum in children: a systematic review
|Family Practice|2013|121